|
AKTIP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.45410000005086E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.72980000000744E-05 |
| Normal-vs-Stage2 |
5.752400E-01 |
| Normal-vs-Stage3 |
3.28279999994852E-06 |
| Normal-vs-Stage4 |
1.5284799999904E-05 |
| Stage1-vs-Stage2 |
1.349980E-02 |
| Stage1-vs-Stage3 |
1.956250E-01 |
| Stage1-vs-Stage4 |
9.323900E-02 |
| Stage2-vs-Stage3 |
3.640300E-03 |
| Stage2-vs-Stage4 |
2.979200E-03 |
| Stage3-vs-Stage4 |
5.390600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.01679999975346E-07 |
| Normal-vs-AfricanAmerican |
1.953000E-01 |
| Normal-vs-Asian |
9.124500E-03 |
| Caucasian-vs-AfricanAmerican |
1.232980E-01 |
| Caucasian-vs-Asian |
1.601240E-01 |
| AfricanAmerican-vs-Asian |
6.812600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.52310999999017E-05 |
| Normal-vs-Female |
4.02040000000436E-05 |
| Male-vs-Female |
2.984600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.83087999999776E-05 |
| Normal-vs-Age(41-60Yrs) |
4.616200E-04 |
| Normal-vs-Age(61-80Yrs) |
5.8066999999995E-05 |
| Normal-vs-Age(81-100Yrs) |
6.160000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.889200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.630200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.606800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.856400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.416000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.235400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.140210E-03 |
| Classical-VS-Follicular |
4.627600E-04 |
| Classical-VS-Other |
5.444800E-01 |
| Classical-VS-Normal |
4.35060000000265E-05 |
| Tall-VS-Follicular |
1.84839999972652E-07 |
| Tall-VS-Other |
3.850600E-01 |
| Tall-VS-Normal |
1.2359000045592E-08 |
| Follicular-VS-Other |
1.179390E-01 |
| Follicular-VS-Normal |
7.381200E-01 |
| Other-VS-Normal |
1.234000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.998580E-03 |
| Normal-vs-N1 |
4.95959999957662E-07 |
| N0-vs-N1 |
9.116400E-03 |
|
|
